Rosa Falcone
Rome, 00167, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis.
Journal: Cancers
Published: February 10, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Case Report: The role of BRAF mutation in adjuvant and neoadjuvant treatment of melanoma patients: what is the optimal approach?
Journal: Frontiers in oncology
Published: December 25, 2025
Hematologic immune-related adverse events in skin cancer patients treated with immune checkpoint inhibitors: a case series.
Journal: Frontiers in pharmacology
Published: October 02, 2025
Application of Radiomics in Melanoma: A Systematic Review and Meta-Analysis.
Journal: Cancers
Published: August 04, 2025
Practical recommendations for oncological psoriatic patients: flow chart and statement.
Journal: Italian journal of dermatology and venereology
Published: April 03, 2025
The role of miR-335-5p in the redifferentiation of BRAF p.V600E thyroid cancers.
Journal: Molecular oncology
Published: April 02, 2025
Anorectal melanoma: Clinico-pathological features of a rare and aggressive malignancy in a multicentric study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 16, 2025
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience.
Journal: BMC cancer
Published: August 05, 2024
Last Updated: 09/26/2026